HIT Consultant
AUGUST 5, 2022
What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%
HIT Consultant
JANUARY 14, 2022
Empowering Physicians & Life Science Companies. In October 2021, Verana Health launched its VeraQ™ population health data engine, which is clinician-directed and enhanced by AI to securely power a data integrity feedback loop of nearly a half-billion, de-identified healthcare encounters. Expansion Plans.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
OCTOBER 13, 2022
What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,
HIT Consultant
JUNE 30, 2022
The new research reveals perspectives on the life sciences industry based on an extensive analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010–2021. However, the pace of innovation in life sciences is at an all-time high. Inorganic Growth Strategy.
GoMoHealth
DECEMBER 9, 2021
Trajectory’s clients span industry segments of consumer health and wellness, healthcare providers and payers, medical practices/integrative health and wellness, skin care and beauty, including Atlantic Health System, CareOne, IDCare, NeoStrata, Perma Blend, Progyny, Sylvania and Tower Health.
Cloud Blogs
MAY 18, 2021
Integrating AI and machine learning into the healthcare ecosystem allows for a variety of benefits, including automating administrative tasks, easing workflows, and analyzing large data sets to deliver better healthcare faster, and at a lower cost.
HIT Consultant
OCTOBER 26, 2023
What You Should Know: – Georgiamune , a privately held, clinical stage biotechnology company, and Verily , an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
Expert insights. Personalized for you.
98 
Let's personalize your content